{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:26:44Z","timestamp":1790922404197,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Breast cancer is divided into four molecular subtypes. Each one has distinct clinical features. The aim of this study was to assess individual breast cancer subtype risk in premenopausal women taking oral contraceptives (OCs). Databases (MEDLINE; PubMed, EMBASE, and the Cochrane Library) were searched to January 2022 to identify case-control studies meeting the inclusion criteria. The influence of OCs intake on the risk of ER-positive breast cancer (ER+BC) was revealed to be non-significant with regard to reduction: OR = 0.9134, 95% CI: 0.8128 to 1.0265, p = 0.128. Assessment of ER-negative subtype breast cancer (ER\u2212BC) risk indicated that OCs use significantly increased the risk: OR = 1.3079, 95% CI: 1.0003 to 1.7100, p = 0.050. Analysis for HER2-positive breast cancer (HER2+BC) risk showed that OCs use statistically non-significantly lowered the risk: OR = 0.8810, 95% CI: 0.5977 to 1.2984, p = 0.522. Meta-analysis with regard to Triplet-negative breast cancer (TNBC) risk showed non-statistically significant increased risk: OR = 1.553, 95% CI: 0.99 to 2.43, p = 0.055. The findings of the meta-analysis suggest that breast cancer risk in premenopausal women may vary with respect to molecular subtypes. Extensive scientific work is still necessary in order to understand the impact of OCs use on breast cancer risk in young women.<\/jats:p>","DOI":"10.3390\/ijerph192215363","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T03:05:11Z","timestamp":1668999911000},"page":"15363","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral Contraceptive Use and Assessment of Breast Cancer Risk among Premenopausal Women via Molecular Characteristics: Systematic Review with Meta-Analysis"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4864-0184","authenticated-orcid":false,"given":"Agnieszka","family":"Bara\u0144ska","sequence":"first","affiliation":[{"name":"Department of Medical Informatics and Statistics with e-Health Lab, Medical University of Lublin, 20-094 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"\u0141ukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., and Stanis\u0142awek, A. (2021). Breast Cancer\u2014Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies\u2014An Updated Review. Cancers, 13.","DOI":"10.3390\/cancers13174287"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10549-020-06083-6","article-title":"Global, regional, national burden of breast cancer in 185 countries: Evidence from GLOBOCAN 2018","volume":"187","author":"Sharma","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/tbj.12358","article-title":"Considerations for comprehensive assessment of genetic predisposition in familial breast cancer","volume":"21","author":"Lynch","year":"2015","journal-title":"Breast J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/cncr.32887","article-title":"Breast cancer early detection: A phased approach to implementation","volume":"126","author":"Ginsburg","year":"2020","journal-title":"Cancer"},{"key":"ref_6","first-page":"e23683","article-title":"Epidemiology of Carcinoma Breast in Young Adolescence Women","volume":"14","author":"Latif","year":"2022","journal-title":"Cureus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr2647","article-title":"Breast cancer in young women","volume":"12","author":"Gabriel","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1007\/s00520-022-06852-7","article-title":"Psychosocial issues and quality of life of parenting partners of young women with breast cancer","volume":"30","author":"Borstelmann","year":"2022","journal-title":"Support. Care Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/pon.744","article-title":"Psychosocial problems among younger women with breast cancer","volume":"13","author":"Avis","year":"2004","journal-title":"Psychooncology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-022-06576-6","article-title":"Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: A national multicentre cohort study","volume":"194","author":"Howell","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"689028","DOI":"10.3389\/fcell.2021.689028","article-title":"Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity","volume":"1","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clbc.2012.07.001","article-title":"Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer","volume":"12","author":"Munzone","year":"2012","journal-title":"Clin. Breast Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/tbj.12059","article-title":"rognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women","volume":"19","author":"Ferguson","year":"2013","journal-title":"Breast J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr2890","article-title":"Microarrays in the 2010s: The contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction","volume":"13","author":"Colombo","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.ajpath.2017.08.002","article-title":"Discerning clinical responses in breast cancer based on molecular signatures","volume":"187","author":"Coleman","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/CEJ.0b013e3283639f7a","article-title":"Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status","volume":"23","author":"Rosato","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctrv.2016.07.006","article-title":"Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies","volume":"49","author":"Lambertini","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/djj376","article-title":"Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women","volume":"98","author":"Hankinson","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_19","first-page":"73","article-title":"Established breast cancer risk factors and risk of intrinsic tumor subtypes","volume":"1856","author":"Barnard","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_20","first-page":"R9","article-title":"Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet beta- and MIN6 cells","volume":"208","author":"Gonzalez","year":"2011","journal-title":"J. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bardaweel, S.K., Akour, A.A., Al-Muhaissen, S., AlSalamat, H.A., and Ammar, K. (2019). Oral contraceptive and breast cancer: Do benefits outweigh the risks? A case\u2014Control study from Jordan. BMC Women Health, 19.","DOI":"10.1186\/s12905-019-0770-x"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kanadys, W., Bara\u0144ska, A., Malm, M., B\u0142aszczuk, A., Polz-Dacewicz, M., Janiszewska, M., and J\u0119drych, M. (2021). Use of oral contraceptives as a potential risk factor for breast cancer: A systematic review and meta-analysis of case-control studies up to 2010. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18094638"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bara\u0144ska, A., B\u0142aszczuk, A., Kanadys, W., Malm, M., Drop, K., and Polz-Dacewicz, M. (2021). Oral contraceptive use and breast cancer risk assessment: A systematic review and meta-analysis of case-control studies, 2009\u20132020. Cancers, 13.","DOI":"10.3390\/cancers13225654"},{"key":"ref_24","first-page":"2228","article-title":"Contemporary Hormonal Contraception and the Risk of Breast Cancer","volume":"77","author":"Skovlund","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive use and breast cancer: A prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bara\u0144ska, A., Dolar-Szczasny, J., Kanadys, W., Kinik, W., Ceglarska, D., Religioni, U., and Rejdak, R. (2022). Oral contraceptive use and breast cancer risk according to molecular subtypes status: A systematic review and meta-analysis of case-control studies. Cancers, 14.","DOI":"10.3390\/cancers14030574"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1742-1241.2009.02168.x","article-title":"Health Outcomes, Policy, and Economics (HOPE) Collaborative Group. Understanding heterogeneity in meta-analysis: The role of meta-regression","volume":"63","author":"Baker","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"ref_33","first-page":"413","article-title":"Oral contraceptive use and other risk factors in relation to HER-2\/neu overexpression in breast cancer among young women","volume":"8","author":"Gammon","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/sj.bjc.6601293","article-title":"Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status","volume":"89","author":"McCredie","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_35","first-page":"1053","article-title":"Hormonal factors and the risk of breast cancer according to estrogen and progesterone-receptor subgroup","volume":"12","author":"Cotterchio","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","article-title":"Risk factors for triple-negative breast cancer in women under the age of 45 years","volume":"18","author":"Dolle","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/0008-5472.CAN-09-3460","article-title":"Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women\u2019s contraceptive and reproductive experiences study","volume":"70","author":"Ma","year":"2010","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10549-012-2365-1","article-title":"Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20\u201344 years of age","volume":"137","author":"Li","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","article-title":"Oral contraceptives and breast cancer risk overall and by molecular subtype among young women","volume":"23","author":"Beaber","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/1055-9965.EPI-17-0450","article-title":"Biology and etiology of young-onset breast cancers among premenopausal African American women: Results from the AMBER Consortium","volume":"26","author":"Olshan","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/ijc.31258","article-title":"Reproductive history, breast-feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study","volume":"142","author":"John","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/mco.2017.1259","article-title":"Association between oral contraceptive use as a risk factor and triple-negative breast cancer: A systematic review and meta-analysis","volume":"7","author":"Li","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13058-015-0535-x","article-title":"A case\u2013control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium","volume":"17","author":"Bethea","year":"2015","journal-title":"Breast Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10549-011-1616-x","article-title":"Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger","volume":"130","author":"Gaudet","year":"2011","journal-title":"Breast Cancer Res. Treat."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/15363\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:22:36Z","timestamp":1760145756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/15363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":45,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijerph192215363"],"URL":"https:\/\/doi.org\/10.3390\/ijerph192215363","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]}}}